The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
- Vincent C.J. van de Vlasakker
- , Robin J. Lurvink
- , Peter H. Cashin
- , Wim Ceelen
- , Marcello Deraco
- , Diane Goéré
- , Santiago González-Moreno
- , Kuno Lehmann
- , Yan Li
- , Brendan Moran
- , David L. Morris
- , Pompiliu Piso
- , Claudio A. Quadros
- , Beate Rau
- , S. P. Somashekhar
- , Antonio Sommariva
- , Kurt van der Speeten
- , John Spiliotis
- , Paul H. Sugarbaker
- , Melissa C.C. Teo
*Corresponding author for this work
- Catharina Hospital
- Uppsala University
- Ghent University Hospital
- National Cancer Institute of Milan
- Institut Gustave Roussy
- MD Anderson Cancer Center Madrid
- University Hospital Zurich
- Beijing Shijitan Hospital
- Hampshire Hospitals NHS Foundation Trust
- The St George Hospital
- Hospital Barmherzige Brüder
- Hospital São Rafael
- Charité - University Medicine Berlin
- Manipal Comprehensive Cancer Center
- University of Padova and Istituto Oncologico Veneto
- Ziekenhuis Oost-Limburg
- European Interbalkan Medical Center
- Washington Hospital Center
- National Cancer Centre Singapore
- Kishiwada Tokushukai Hospital
- Lyon Sud Hospital Center
- Maastricht University
Research output: Contribution to journal › Journal article › Research › peer-review